Biomaterial Database

Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes. 1976

M S Simberkoff, and I Ricupero, and J J Rahal

Serratia marcescens strains isolated from clinical specimens can be divided into those which are sensitive or resistant to the bactericidal activity of normal human serum. Serum bactericidal activity is heat labile, cation dependent, and is absorbable by whole, serum-sensitive Serratia or ethanol-insoluble extracts of these organisms. Bacteremic Serratia infection is invariably caused by the serum-resistant strains. Serum resistant Serratia are ingested and killed by normal human leukocytes and fresh normal serum. Heating or preabsorption of serum with whole, heat-killed, or ethanol-insoluble antigen extracts of the serum-resistant Serratia diminishes opsonization and phagocytosis. Serratia opsonins in the serum of healthy individuals are type-specific IgM globulins which combine with the organism and activate complement by the alternate pathway.

UI	MeSH Term	Description	Entries
D007962	Leukocytes	White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).	Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008826	Microbial Sensitivity Tests	Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).	Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010101	Oxygen Consumption	The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346)	Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010587	Phagocytosis	The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES).	Phagocytoses
D001770	Blood Bactericidal Activity	The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST.	Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D003428	Cross Infection	Any infection which a patient contracts in a health-care institution.	Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004756	Enterobacteriaceae Infections	Infections with bacteria of the family ENTEROBACTERIACEAE.	Enterobacterial Infections,Cronobacter Infections,Infections, Enterobacteriaceae,Infections, Enterobacterial,Cronobacter Infection,Enterobacteriaceae Infection,Enterobacterial Infection,Infection, Cronobacter,Infection, Enterobacteriaceae,Infection, Enterobacterial,Infections, Cronobacter
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012703	Serotyping	Process of determining and distinguishing species of bacteria or viruses based on antigens they share.	Serotypings
D012706	Serratia marcescens	A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.

Related Publications

M S Simberkoff, and I Ricupero, and J J Rahal

Intracellular survival and growth of Serratia marcescens following phagocytosis by human leukocytes.

April 1968, The Journal of infectious diseases,

M S Simberkoff, and I Ricupero, and J J Rahal

Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.

January 1981, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious...,

M S Simberkoff, and I Ricupero, and J J Rahal

Failure of the commercial human IgG immunoglobulin preparation Polyglobin to enhance combined phagocytic and serum bactericidal activity of normal blood against Serratia marcescens.

January 1983, Chemotherapy,

M S Simberkoff, and I Ricupero, and J J Rahal

Stimulation and inhibition of polymorphonuclear leukocytes phagocytosis by lipoamino acids isolated from Serratia marcescens.

April 1993, FEMS immunology and medical microbiology,

M S Simberkoff, and I Ricupero, and J J Rahal

[Phagocytosis and bactericidal activity of human leukocytes].

September 1977, Bruxelles medical,

M S Simberkoff, and I Ricupero, and J J Rahal

Phagocytosis of Serratia marcescens by leukocytes of fresh defibrinated human blood: failure of "natural" human specific anti-O IgG antibodies to enhance phagocytosis.

M S Simberkoff, and I Ricupero, and J J Rahal